These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 6316799

  • 1. Laboratory assessment of disappearance patterns of human chorionic gonadotropin from serum of patients with gestational trophoblastic disease.
    Boots LR, Hatch KD, Younger JB.
    Ala J Med Sci; 1983 Oct; 20(4):391-4. PubMed ID: 6316799
    [No Abstract] [Full Text] [Related]

  • 2. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB, Lehr M, Lewis JL.
    Surg Forum; 1973 Oct; 24():563-5. PubMed ID: 4377042
    [No Abstract] [Full Text] [Related]

  • 3. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ, Ruf H, Blanc B, Gamerre M, Adrai J, Conte M, Dupont S, Bellia-Rousseau J.
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [Abstract] [Full Text] [Related]

  • 4. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 5. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM, Seppälä M.
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract] [Full Text] [Related]

  • 6. Serum testosterone and dihydrotestosterone in patients with trophoblastic disease.
    Dawood MY, Saxena BB.
    Obstet Gynecol; 1976 Jun; 47(6):684-8. PubMed ID: 180465
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 8. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 9. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P, Leyendecker G.
    Arch Gynecol; 1979 Jul 20; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract] [Full Text] [Related]

  • 10. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
    Tuncer ZS, Bernstein MR, Goldstein DP, Berkowitz RS.
    Gynecol Oncol; 1999 Jun 20; 73(3):345-7. PubMed ID: 10366457
    [Abstract] [Full Text] [Related]

  • 11. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
    Norman RJ, Buck RH, Joubert SM.
    S Afr Med J; 1989 Apr 01; 75(7):318-9. PubMed ID: 2538933
    [Abstract] [Full Text] [Related]

  • 12. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E.
    Obstet Gynecol; 2006 Mar 01; 107(3):743. PubMed ID: 16507954
    [No Abstract] [Full Text] [Related]

  • 13. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA, Schlaerth JB, Ahn C, Sauer MV.
    Gynecol Oncol; 1994 Sep 01; 54(3):288-91. PubMed ID: 7522199
    [Abstract] [Full Text] [Related]

  • 14. New criteria for the diagnosis of gestational trophoblastic disease.
    Romero R, Horgan JG, Kohorn EI, Kadar N, Taylor KJ, Hobbins JC.
    Obstet Gynecol; 1985 Oct 01; 66(4):553-8. PubMed ID: 2995891
    [Abstract] [Full Text] [Related]

  • 15. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia.
    Rotmensch J, Rosenshein NB, Block BS.
    Gynecol Oncol; 1988 Jan 01; 29(1):82-6. PubMed ID: 2448190
    [Abstract] [Full Text] [Related]

  • 16. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N.
    Akush Ginekol (Sofiia); 1989 Jan 01; 28(2):15-9. PubMed ID: 2548413
    [Abstract] [Full Text] [Related]

  • 17. Persistent gestational trophoblastic disease after a diploid partial hydatidiform mole coexisting with a normal living fetus.
    Cheung NY, Ngan HY, Ghosh A.
    Int J Gynaecol Obstet; 1992 Jul 01; 38(3):238-9. PubMed ID: 1360430
    [No Abstract] [Full Text] [Related]

  • 18. Measurement of human chorionic gonadotropin.
    Goldstein DP, Berkowitz RS, Kosasa TS.
    Major Probl Obstet Gynecol; 1982 Jul 01; 14():64-97. PubMed ID: 6273663
    [No Abstract] [Full Text] [Related]

  • 19. [Changes in serum human chorionic gonadotropin in patients with hydatidiform mole following evacuation].
    Wang X.
    Zhonghua Fu Chan Ke Za Zhi; 1988 Nov 01; 23(6):362-4, 388. PubMed ID: 2854773
    [No Abstract] [Full Text] [Related]

  • 20. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI.
    Gynecol Oncol; 2002 May 01; 85(2):315-20. PubMed ID: 11972394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.